Emotional support study for pancreatic cancer patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study offers a brief psychological intervention to help patients with pancreatic cancer manage emotional well-being before surgery. It is designed for newly diagnosed patients who are starting chemotherapy before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with localized pancreatic cancer.
- You plan to start chemotherapy before surgery.
- You have not already received 2 or more cycles of chemotherapy.
- You are not a prisoner.
- You are able to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized website program called COMPASS designed to help people with stage I-III pancreatic cancer improve their exercise and diet while receiving chemotherapy before surgery. The goal is to see if this program helps patients feel better and stay stronger during treatment.
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
This study looks at ways to improve nutrition and strength for people with pancreatic cancer who are undergoing chemotherapy or radiation. Participation may help you maintain your strength and well-being during treatment.
This trial studies an “implementation program” to help patients with locally advanced pancreatic cancer get ready for the next steps after chemotherapy. It may help improve care planning and outcomes for people whose cancer has not grown after initial treatment.
This trial tests an 8-week exercise and nutrition program for people with pancreatic or stomach cancer before they start chemotherapy. The goal is to see if this program helps patients stay stronger and better able to handle treatment.
This Phase 2 trial is for people with pancreatic ductal adenocarcinoma (a type of pancreatic cancer) confirmed by biopsy. It tests a new treatment strategy after the cancer is diagnosed and considers people who haven’t had certain chemotherapy yet.
Hear when a new Stage I Pancreatic Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.